NIMR Mbeya(@NIMRMbeya) 's Twitter Profileg
NIMR Mbeya

@NIMRMbeya

NIMR Mbeya conducts medical research on HIV/AIDS, Tuberculosis (TB), Ebola, Malaria and other relevant tropical diseases while evaluating clinical trials etc.

ID:932857967644463105

linkhttp://mbeya.nimr.or.tz/ calendar_today21-11-2017 06:27:25

837 Tweets

2,5K Followers

415 Following

Ifakara Health Institute(@ifakarahealth) 's Twitter Profile Photo

๐Ÿฉบ :
Our commitment to health as a right for all

In alignment with World Health Day 2024, Ifakara Health Institute is proud to feature a series of insights focusing on this year's theme from our team of dedicated scientists and health experts๐Ÿ”ฌ

Chief Executive

๐Ÿฉบ #WHD2024: Our commitment to health as a right for all In alignment with World Health Day 2024, @ifakarahealth is proud to feature a series of insights focusing on this year's theme #MyHealthMyRight from our team of dedicated scientists and health experts๐Ÿ”ฌ Chief Executive
account_circle
NIMR Mbeya(@NIMRMbeya) 's Twitter Profile Photo

Meet our very own Dr. Elizabeth Ntapara ๐Ÿ‘
Her passion and skills in clinical research are indeed remarkable; and her research journey carry forth studies on HIV vaccines, Ebola, NTDs and PrEP
Congratulations on this recognition as part of the Tanzania Immunology Society team

account_circle
Ifakara Health Institute(@ifakarahealth) 's Twitter Profile Photo

FORUM:
Ifakara at the Primary Health Care Conference 2024

From March 25-27, 2024, Ifakara Health Institute has been participating in the 1st International Primary Health Care Conference ( ) held at the Jakaya Kikwete Convention Centre in Dodoma, Tanzania.

This conference,

FORUM: Ifakara at the Primary Health Care Conference 2024 From March 25-27, 2024, @ifakarahealth has been participating in the 1st International Primary Health Care Conference (#IPHCC2024) held at the Jakaya Kikwete Convention Centre in Dodoma, Tanzania. This conference,
account_circle
TB Sequel(@TBSequel) 's Twitter Profile Photo

Today on we would like to raise awareness on TB and post-TB associated disabilities, especially post-TB lung disease (PTLD). We have listed useful resources, co-authored or co-created by colleagues (see comments) 2024

Today on #WorldTBDay we would like to raise awareness on TB and post-TB associated disabilities, especially post-TB lung disease (PTLD). We have listed useful resources, co-authored or co-created by #TBSequel colleagues (see comments) #EndTB #WorldTBDay2024 #PTLD
account_circle
CDC(@CDCgov) 's Twitter Profile Photo

On , we recognize individuals, groups, and organizations as global TB elimination champions. Through their relentless pursuit of a world free from TB, together, .

See our 2024 champions here: bit.ly/49JiYTf.

On #WorldTBDay, we recognize individuals, groups, and organizations as global TB elimination champions. Through their relentless pursuit of a world free from TB, together, #YesWeCanEndTB. See our 2024 champions here: bit.ly/49JiYTf.
account_circle
NIMR Mbeya(@NIMRMbeya) 's Twitter Profile Photo

As we approach World TB Day 2024, our community engagement team organised a TB sensitisation workshop for Health Facilities and healthcare workers within Songwe and Mbeya regions as key stakeholders in the fight against TB
# Yes!ย We can end TB

As we approach World TB Day 2024, our community engagement team organised a TB sensitisation workshop for Health Facilities and healthcare workers within Songwe and Mbeya regions as key stakeholders in the fight against TB # Yes!ย We can end TB
account_circle
Infect-Net(@InfectNet) 's Twitter Profile Photo

Together with colleagues from Instituto Nacional de Saรบde โ€“ INS NIMR Mbeya Karolinska Institutet& funded by EDCTP we are currently involved in an exciting study ERASE-TB โ€“ investigating novel tests for earlier diagnosis - tinyurl.com/4mdxhecw

Together with colleagues from @instituto_ins @NIMRMbeya @karolinskainst& funded by @EDCTP we are currently involved in an exciting study @EraseTb โ€“ investigating novel tests for earlier diagnosis - tinyurl.com/4mdxhecw
account_circle
MHRP(@MHRPInfo) 's Twitter Profile Photo

Our annual science meetings continued today with a focus on vaccines and prevention. Presentations featured updates on ongoing clinical trials, promising bi-specific broadly neutralizing antibodies, novel vaccine strategies and future development. 1/2

Our annual science meetings continued today with a focus on vaccines and prevention. Presentations featured updates on ongoing clinical trials, promising bi-specific broadly neutralizing antibodies, novel vaccine strategies and future #HIVvaccine development. 1/2
account_circle
NIMR Tanzania(@NIMR_Tanzania) 's Twitter Profile Photo

๐—ก๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—œ๐—ป๐˜€๐˜๐—ถ๐˜๐˜‚๐˜๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต - ๐— ๐—ฏ๐—ฒ๐˜†๐—ฎ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—–๐—ฒ๐—ป๐˜๐—ฒ๐—ฟ (๐—ก๐—œ๐— ๐—ฅ-๐— ๐— ๐—ฅ๐—–) ๐—•๐—ฒ๐—ด๐—ถ๐—ป๐˜€ ๐—”๐—ป๐˜๐—ถ๐—ฏ๐—ผ๐—ฑ๐˜† ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฆ๐˜๐˜‚๐—ฑ๐˜† ๐˜๐—ผ ๐—œ๐—ป๐—ณ๐—ผ๐—ฟ๐—บ ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ ๐—ผ๐—ณ ๐—ก๐—ผ๐˜ƒ๐—ฒ๐—น ๐—›๐—œ๐—ฉ

๐—ก๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—œ๐—ป๐˜€๐˜๐—ถ๐˜๐˜‚๐˜๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต - ๐— ๐—ฏ๐—ฒ๐˜†๐—ฎ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—–๐—ฒ๐—ป๐˜๐—ฒ๐—ฟ (๐—ก๐—œ๐— ๐—ฅ-๐— ๐— ๐—ฅ๐—–) ๐—•๐—ฒ๐—ด๐—ถ๐—ป๐˜€ ๐—”๐—ป๐˜๐—ถ๐—ฏ๐—ผ๐—ฑ๐˜† ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฆ๐˜๐˜‚๐—ฑ๐˜† ๐˜๐—ผ ๐—œ๐—ป๐—ณ๐—ผ๐—ฟ๐—บ ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ ๐—ผ๐—ณ ๐—ก๐—ผ๐˜ƒ๐—ฒ๐—น ๐—›๐—œ๐—ฉ
account_circle